Biotech · Private company
Global Blood Therapeutics
Track this companyFree. Adds Global Blood Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- GBT440Phase 2 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- GBT440Phase 1 · Cardio-pulmonary FunctionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney DiseasePHASE1_PHASE2 · TERMINATED · started Mar 16, 2021ClinicalTrials.gov NCT04335721 · fetched Nov 12, 2026
- Voxelotor Sickle Cell Exercise StudyPHASE4 · COMPLETED · started Sep 21, 2020ClinicalTrials.gov NCT04581356 · fetched Nov 12, 2026
- Study to Evaluate Effects of Investigational Drug on Oxygenation in Healthy Volunteers Under Hypoxic ConditionsPHASE1 · TERMINATED · started Dec 1, 2016ClinicalTrials.gov NCT03051711 · fetched Nov 12, 2026
- Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at RestPHASE2 · TERMINATED · started Nov 1, 2016ClinicalTrials.gov NCT02989168 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPFPHASE2 · COMPLETED · started Jun 1, 2016ClinicalTrials.gov NCT02846324 · fetched Nov 12, 2026